New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine materials were contaminated, the lawsuit said.
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine materials were contaminated, the lawsuit said.
What's Your Reaction?
